Blog

Landing Page Optimization for Digital Health

by Jason Shafton

Digital health buyers show up skeptical – they have watched too many apps promise results and deliver little more than a subscription. A page designed for e-commerce or generic SaaS buckles under that skepticism. We rebuild and test the landing page itself – messaging, offer, proof, and trust signals – until it converts a cautious health buyer, not merely a curious clicker.

The Challenge

Your page makes a clinical-sounding claim, but visitors leave because they don't trust it

Health and wellness landing pages default to outcome language – 'lower your A1C', 'improve your sleep', 'reduce anxiety' – because that is what the product does. But a first-time visitor has no reason to believe a landing page making that claim, and regulatory caution usually forces the copy into vague, hedged language that persuades no one. The result is a page that is simultaneously overpromising to a skeptic and underexplaining to someone who wants specifics. Conversion rate reflects that mismatch directly – visitors leave rather than resolve the tension themselves.

You are testing button colors while the real objection – trust, safety, efficacy – remains unanswered

Most landing page optimization programs run shallow tests: headline word swaps, CTA button color, hero image variant. None of that moves the needle for a digital health buyer whose real hesitation is whether this is legitimate, whether it is safe, and whether a person like them has used it successfully. Testing the wrong variable burns weeks of traffic and produces flat results that get blamed on the market instead of the test design. The lift is sitting in the objection nobody is testing against.

Compliance review brings every page update to a crawl, causing testing velocity to collapse

Digital health marketing teams answer to legal and clinical reviewers who have to sign off on any claim before it goes live, which is reasonable given the regulatory exposure but devastating for iteration speed. A team that can normally ship a new variant in two days is stuck at two weeks because every headline touches a claims review queue. By the time a test result comes back, the market context that motivated the test has often already shifted, and the learning arrives too late to compound.

The page converts visitors who leave in month one because it set the wrong expectation

A landing page optimized purely for click-through and signup rate will often win by overpromising speed or ease, pulling in users who are the wrong fit and churn fast once the real product experience doesn't match the pitch. That inflates top-of-funnel conversion while quietly wrecking trial-to-paid and 90-day retention. In digital health, where CAC is already elevated by compliance and channel costs, acquiring the wrong user is more expensive than acquiring fewer of the right ones.

How We Can Help

We begin by auditing the page against the real sequence of objections a health buyer works through before converting – rather than using a standard SaaS checklist.

We then create a testing roadmap that starts with the highest-leverage variables – message framing, offer structure, and trust signal placement – rather than surface-level changes.

For execution, we create the variants, configure the experiment within your current testing stack, and – crucially – incorporate claims review into the testing cadence instead of treating it as a bottleneck to work around.

We also directly rebuild the page's trust layer – clinical credentials, data-privacy language, third-party validation, and social proof suited to a health buyer rather than copied from consumer e-commerce.

For measurement, we monitor conversion rate together with downstream quality metrics – trial-to-paid conversion, plus 30- and 90-day retention for page-driven signups – so any test that lifts top-line conversion while hurting downstream quality is caught before being named a winner.

This approach is different because we treat the compliance process as a system to optimize, not as an obstacle beyond our scope.

What we deliver

The best-converting digital health landing page isn't the one with the boldest claim – it's the one that answers 'why should I believe this' before visitors need to ask. Optimize for belief rather than clicks alone, and the downstream churn issue largely resolves itself.

Our Methodology

We deliver landing page optimization through a 90-day sprint. The opening 30 days cover audit and roadmap: we analyze session recordings and funnel data to uncover the true objection points, create a prioritized testing list, and – at the same time – collaborate with your legal and clinical reviewers to pre-clear a library of claim variations so later testing does not stall. Days 30 through 60 cover building and launching: we release the first wave of messaging, offer, and trust-signal tests, set up tracking for conversion and downstream quality, and begin evaluating results against a clean baseline. Days 60 through 90 move into iteration – we make winning variants the control, launch another test wave based on lessons from the first round, and leave your team with a testing cadence it can continue operating.

The difference from a typical CRO engagement is that we account for digital health's regulatory reality from day one rather than encountering it halfway through the sprint. Most CRO agencies create test plans on the assumption that a new headline can ship within a day; in digital health, that assumption fails as soon as legal flags a claim, bringing the entire roadmap to a halt. We address that limitation directly by pre-clearing claims language and creating tests that adjust structure and proof instead of demanding net-new medical claims every time.

Engagements often continue beyond the first sprint because testing programs compound – every finding focuses the target of the next test, while traffic levels in health verticals frequently require more weeks to reach significance than high-traffic consumer products. We remain involved as an operating partner rather than conducting a one-off audit, managing the cadence quarter after quarter as your audience and offer develop.

The Insights You Want

Right in your inbox. We’ve done the work, and now we’re sharing it with you. Sign up to stay in the loop.

Get The Latest Updates


Enter your email address

Our Working Process

The initial 30 days center on auditing and pre-clearance. We assess your current page performance, pinpoint where health-buyer skepticism is reducing conversion, and have a library of claim variations approved by your legal and clinical reviewers before launching even one test – protecting the remainder of the sprint from delays caused by review cycles.

Days 30 through 60 focus on building and launching. We create and release the first test round within your current testing stack (Optimizely, VWO, or a native A/B setup), collaborating with your engineering or web team instead of requiring another platform. From your team, we require access to analytics and session recording tools, along with a designated reviewer for anything beyond the pre-cleared claims library.

Days 60 through 90 cover iteration and handoff. We evaluate results through significance, put winning variants live, and begin a second testing wave informed by the first round's findings. We provide a documented testing cadence and prioritized backlog, enabling your team to continue testing between engagements whether or not you choose to extend with us.

Our schedule includes a weekly working session to assess test performance and unblock anything delayed in review, supported by async reports on conversion and downstream quality metrics. Because of the traffic and significance limitations typical in digital health, initial engagements generally last three to six months, with many clients moving into an ongoing quarterly testing rhythm.

If your digital health company needs landing page optimization leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

What does landing page optimization cost for a digital health company?

We charge a fixed engagement fee based on your traffic volume, the planned number of test variants, and the amount of trust-layer creative work required alongside testing. One high-traffic page with a focused testing roadmap costs less than a broader program covering several product lines or claim categories.

How soon can we expect an increase in conversion rate?

The initial test wave generally launches by day 45-60 after the claims library is cleared and the audit is finished, with directional findings emerging within two to four weeks of launch depending on traffic volume. Achieving statistical significance may take longer in digital health than in high-traffic consumer verticals simply because less traffic is available, so we establish realistic timelines for each test instead of guaranteeing a fixed date.

How does the optimization team collaborate with our current marketing and legal teams?

We partner directly with your growth or marketing team to design tests and with your legal and clinical reviewers to pre-clear claims, acting as an embedded extension of both teams instead of a vendor that simply delivers a report. We require access to your analytics and testing platform, as well as a designated contact for review approval.

How is Winston Francois different from a conventional CRO agency?

A typical CRO agency applies a standard e-commerce playbook to test headlines and button colors, then has no solution when your legal team flags a claim during the sprint. From day one, we incorporate compliance pre-clearance into the testing roadmap and prioritize tests around a health buyer's specific trust and belief concerns, rather than generic conversion techniques taken from other verticals.

How is ROI measured for a landing page optimization engagement?

We measure conversion rate improvement against your pre-engagement baseline, while balancing it against downstream quality – trial-to-paid conversion and 30/90-day retention among visitors acquired through the tested page. Any variant that increases signups while reducing retention gets flagged rather than celebrated.

Which type of digital health company is best suited to this service?

This service is best suited to digital health companies with $5M-$100M ARR, meaningful paid or organic traffic flowing to a core landing page, and a claims review process that currently delays testing. It is an especially strong fit when your team believes the page – rather than the traffic source – is limiting conversion.


Related Solutions

Solutions

Top Articles

Frank Growth – Episode 242 – Why AI Slop Backfires with Nicole Cassese

Tuesday, October 20, 2026

Frank Growth – Episode 242 – Why AI Slop Backfires with Nicole Cassese

Episode #242: Nicole Cassese — Scaling brand voice without burning out the people behind it How to keep a brand voice consistent across 1,600+ assets and still protect the team writing them. For marketing leaders, creative directors, and copywriters running high-volume content with AI in the workflow. Nicole Cassese is the associate creative director owning...
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Tuesday, June 16, 2026

Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Episode #224: Alex Roy — Bootstrapping an AI company for 12 years, no funding He founded an AI company in 2014—when AI was a punchline—bootstrapped it with zero outside capital, and landed Fortune 50 clients. For founders and growth operators figuring out how to build (and sell) AI products in a market that shifts every...
Frank Growth – Episode 240 – Commerce for Weirdos with Bryan House

Tuesday, October 6, 2026

Frank Growth – Episode 240 – Commerce for Weirdos with Bryan House

Episode #240: Bryan House – Tearing up the enterprise GTM playbook as a challenger brand Elastic Path cut its website to two forms, its marketing team from 13 people to 3, and its implementation bids to a third of the price of competitors. For B2B leaders at challenger brands whose activity metrics look busy while...
Frank Growth – Episode 241 – What AI Still Can’t Do with Will Sartorius

Tuesday, October 13, 2026

Frank Growth – Episode 241 – What AI Still Can’t Do with Will Sartorius

Episode #241: Will Sartorius – AI didn’t kill the creative job, it moved it How to split ad creative work between AI and people so your ads stop sounding like everyone else’s. For founders and marketers running paid social who launch plenty of ads but learn little from them. Will Sartorius, CEO of Selfmade, took...

See more

Browse Categories

See more

Ready to unlock your growth?

Book Free Call

We take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.